HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

WGRX

Wellgistics Health Inc

Last Close
Apr 28 • 04:00PM ET
3.94
Dollar change
-0.01
Percentage change
-0.25 		%
Healthcare • Pharmaceutical Retailers • USA • NASD
Scroll to Statements
Index- P/E- EPS (ttm)-0.13 Insider Own85.20% Shs Outstand51.94M Perf Week27.10%
Market Cap204.64M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float7.40M Perf Month1.81%
Income-6.86M PEG- EPS next Q- Inst Own- Short Float1.84% Perf Quarter-
Sales18.13M P/S11.29 EPS this Y- Inst Trans0.20% Short Ratio0.82 Perf Half Y-
Book/sh0.13 P/B30.39 EPS next Y- ROA-23.78% Short Interest0.14M Perf Year-
Cash/sh0.02 P/C198.68 EPS next 5Y- ROE-357.65% 52W Range2.32 - 5.69 Perf YTD3.41%
Dividend Est.- P/FCF- EPS past 5Y- ROI-35.55% 52W High-30.76% Beta-
Dividend TTM- Quick Ratio0.13 Sales past 5Y0.00% Gross Margin3.60% 52W Low69.83% ATR (14)0.66
Dividend Ex-Date- Current Ratio0.38 EPS Y/Y TTM-136.98% Oper. Margin-33.90% RSI (14)50.84 Volatility14.29% 19.12%
Employees- Debt/Eq3.73 Sales Y/Y TTM- Profit Margin-37.82% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq1.86 EPS Q/Q-302.90% Payout- Rel Volume0.19 Prev Close3.95
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume165.19K Price3.94
SMA200.27% SMA509.62% SMA2009.62% Trades Volume32,677 Change-0.25%
Apr-24-25 07:40AM
Wellgistics Names Mark DiSiena as New CFO
(ACCESSWIRE)
Apr-15-25 07:40AM
CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price
(ACCESSWIRE)
Apr-10-25 07:40AM
Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue
(ACCESSWIRE) -9.07%
Mar-27-25 08:05AM
Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025
(GlobeNewswire)
Mar-18-25 07:40AM
Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models
(GlobeNewswire) +14.61%
05:18PM Loading…
Mar-04-25 05:18PM
Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure
(GlobeNewswire)
07:40AM
Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND
(GlobeNewswire)
Feb-26-25 07:40AM
Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market
(GlobeNewswire)
Feb-25-25 01:15PM
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
(ACCESS Newswire) -9.90%
Feb-24-25 04:05PM
Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering
(GlobeNewswire) -20.47%
Feb-21-25 08:05AM
Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering
(GlobeNewswire)
Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • theme settings • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.